GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (LTS:0Q1N) » Definitions » Sale Of Investment
中文

Pfizer (LTS:0Q1N) Sale Of Investment

: $46,417 Mil (TTM As of Dec. 2023)
View and export this data going back to 1967. Start your Free Trial

Pfizer's sale of investment for the three months ended in Dec. 2023 was $28,210 Mil. It means Pfizer gained $28,210 Mil from selling investments. Pfizer's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was $46,417 Mil.

Compared with last quarter ($5,441 Mil in Sep. 2023 ), Pfizer gained more money from selling investments in Dec. 2023 ($28,210 Mil).

Pfizer Sale Of Investment Historical Data

The historical data trend for Pfizer's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,340.00 12,730.00 28,096.00 45,462.00 46,417.00

Pfizer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,929.00 11,189.00 1,577.00 5,441.00 28,210.00

Pfizer Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $46,417 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Pfizer's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (LTS:0Q1N) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (LTS:0Q1N) » Definitions » Sale Of Investment
Comparable Companies
AMGN BMY GILD BIIB OGN AMRN SCLX MIRA ABBV MRK LLY JNJ LSE:AZN XSWX:ROG XSWX:NOVN XPAR:SAN LSE:GSK TSE:4519 TSE:4568 SHSE:600276
Traded in Other Exchanges
PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Website
https://www.pfizer.com
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (LTS:0Q1N) Headlines

No Headlines